Arkolith/Insider Trading/TRVI/Form 4

Good Jennifer L

President & CEO, DirectorTrevi Therapeutics, Inc. (TRVI) · full profile →Form 4 · filed Sep 9, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$18K
Net Open-Market Flow
-$18K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 9, 2024Option exercise(M)2K$1.43$3K215K
Sep 9, 2024Sell(S)2K$3.04$6K213K
Sep 6, 2024Option exercise(M)4K$1.43$6K218K
Sep 6, 2024Sell(S)4K$3.03$13K213K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 9, 2024Option exercise(M)2K—$00
Sep 6, 2024Option exercise(M)4K—$02K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-104804) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML